197 related articles for article (PubMed ID: 31442497)
1. Recommended Change in the N Descriptor Proposed by the International Association for the Study of Lung Cancer: A Validation Study.
Park BJ; Kim TH; Shin S; Kim HK; Choi YS; Kim J; Zo JI; Shim YM; Cho JH
J Thorac Oncol; 2019 Nov; 14(11):1962-1969. PubMed ID: 31442497
[TBL] [Abstract][Full Text] [Related]
2. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.
Asamura H; Chansky K; Crowley J; Goldstraw P; Rusch VW; Vansteenkiste JF; Watanabe H; Wu YL; Zielinski M; Ball D; Rami-Porta R;
J Thorac Oncol; 2015 Dec; 10(12):1675-84. PubMed ID: 26709477
[TBL] [Abstract][Full Text] [Related]
3. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer.
Park SY; Byun GE; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
Lung Cancer; 2019 Dec; 138():1-5. PubMed ID: 31593893
[TBL] [Abstract][Full Text] [Related]
5. The influence of the number of lymph nodes removed on the accuracy of a newly proposed N descriptor classification in patients with surgically-treated lung cancer.
Dziedzic DA; Cackowski MM; Zbytniewski M; Gryszko GM; Woźnica K; Orłowski TM;
Surg Oncol; 2021 Jun; 37():101514. PubMed ID: 33429325
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis.
Eichhorn F; Klotz LV; Muley T; Kobinger S; Winter H; Eichhorn ME
Lung Cancer; 2019 Dec; 138():95-101. PubMed ID: 31678832
[TBL] [Abstract][Full Text] [Related]
7. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of nodal classification for non-small cell lung cancer by merging current N categories with the number of involved lymph node stations.
Chen W; Zhang C; Wang G; Yu Z; Liu H
Thorac Cancer; 2019 Jul; 10(7):1533-1543. PubMed ID: 31207184
[TBL] [Abstract][Full Text] [Related]
9. External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: the crucial role of histological type, number of resected nodes and adjuvant therapy.
Chiappetta M; Lococo F; Leuzzi G; Sperduti I; Petracca-Ciavarella L; Bria E; Mucilli F; Filosso PL; Ratto GB; Spaggiari L; Facciolo F; Margaritora S
Eur J Cardiothorac Surg; 2020 Dec; 58(6):1236-1244. PubMed ID: 32770184
[TBL] [Abstract][Full Text] [Related]
10. New N1/N2 classification and lobe specific lymphatic drainage: Impact on survival in patients with non-small cell lung cancer treated with surgery.
Tsitsias T; Okiror L; Veres L; King J; Harrison-Phipps K; Routledge T; Pilling J; Bille A
Lung Cancer; 2021 Jan; 151():84-90. PubMed ID: 33250210
[TBL] [Abstract][Full Text] [Related]
11. Does anatomical location-based metastatic lymph node density affect prognosis in lung cancer patients?
Aksoy Y; Çıtak N; Obuz Ç; Metin M; Sayar A
Interact Cardiovasc Thorac Surg; 2021 Oct; 33(4):541-549. PubMed ID: 34000035
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of the number of involved lymph node stations in patients with completely resected non-small cell lung cancer: a proposal for future revisions of the N classification.
Kojima H; Terada Y; Yasuura Y; Konno H; Mizuno T; Isaka M; Funai K; Ohde Y
Gen Thorac Cardiovasc Surg; 2020 Nov; 68(11):1298-1304. PubMed ID: 32449108
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
Park S; Cho S; Yum SW; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
[TBL] [Abstract][Full Text] [Related]
14. Validation of the 8th Edition Nodal Staging and Proposal of New Nodal Categories for Future Editions of the TNM Classification of Non-Small Cell Lung Cancer.
Li S; Yan S; Lu F; Lv C; Wang Y; Li X; Wang Y; Yang Y; Wu N
Ann Surg Oncol; 2021 Aug; 28(8):4510-4516. PubMed ID: 33389296
[TBL] [Abstract][Full Text] [Related]
15. Number of mediastinal lymph nodes in non-small cell lung cancer: a Gaussian curve, not a prognostic factor.
Riquet M; Legras A; Mordant P; Rivera C; Arame A; Gibault L; Foucault C; Dujon A; Le Pimpec Barthes F
Ann Thorac Surg; 2014 Jul; 98(1):224-31. PubMed ID: 24820386
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the proposed classifications for the revision of N descriptors for non-small-cell lung cancer.
Lee GD; Kim DK; Moon DH; Joo S; Hwang SK; Choi SH; Kim HR; Kim YH; Park SI
Eur J Cardiothorac Surg; 2016 Feb; 49(2):580-8. PubMed ID: 25890940
[TBL] [Abstract][Full Text] [Related]
17. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
[TBL] [Abstract][Full Text] [Related]
18. Validity of International Association for the Study Of Lung Cancer proposals for the revision of N descriptors in lung cancer.
Lee JG; Lee CY; Bae MK; Park IK; Kim DJ; Kim KD; Chung KY
J Thorac Oncol; 2008 Dec; 3(12):1421-6. PubMed ID: 19057267
[TBL] [Abstract][Full Text] [Related]
19. Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients.
Li X; Li X; Fu X; Liu L; Liu Y; Zhao H; Li Y; Hu J; Xu L; Liu D; Yang H; Zhang X
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1874-1881. PubMed ID: 31902592
[TBL] [Abstract][Full Text] [Related]
20. Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer.
Jin J; Xu Y; Hu X; Chen M; Fang M; Hang Q; Chen M
Curr Oncol; 2020 Jun; 27(3):e283-e293. PubMed ID: 32669935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
